Skip to main content
. 2020 Dec 1;69(Suppl 4):S541–S553. doi: 10.33549/physiolres.934612

Fig. 4.

Fig. 4

Improvement of doxorubicin-induced cardiovascular damage by a therapy based on Nrf2 activation by quercetin. Blood pressure (A), heart rate (B), SOD activity (C), SOD-2 protein levels (D). DOX – doxorubicin, Q – quercetin. Adapted from Bartekova et al. (2015) and Dovinova et al. (2015b).